Insider Transactions in Q1 2024 at Sarepta Therapeutics, Inc. (SRPT)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 11
2024
|
Kathryn Jean Boor |
SELL
Open market or private sale
|
Direct |
761
-9.19%
|
$92,842
$122.93 P/Share
|
|
Mar 08
2024
|
Ian Michael Estepan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,035
-2.78%
|
$127,305
$123.14 P/Share
|
|
Mar 08
2024
|
Ryan Edward Brown EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
899
-3.04%
|
$110,577
$123.14 P/Share
|
|
Mar 08
2024
|
Louise Rodino Klapac Head of R&D, CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
909
-1.32%
|
$111,807
$123.14 P/Share
|
|
Mar 08
2024
|
Bilal Arif Chief Tech Ops Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
472
-1.84%
|
$58,056
$123.14 P/Share
|
|
Mar 08
2024
|
Hans Lennart Rudolf Wigzell |
SELL
Open market or private sale
|
Direct |
15,000
-14.21%
|
$1,845,000
$123.11 P/Share
|
|
Mar 08
2024
|
Hans Lennart Rudolf Wigzell |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+28.39%
|
$195,000
$13.9 P/Share
|
|
Mar 07
2024
|
Ian Michael Estepan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
526
-1.39%
|
$63,120
$120.49 P/Share
|
|
Mar 07
2024
|
Ryan Edward Brown EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
506
-1.68%
|
$60,720
$120.49 P/Share
|
|
Mar 07
2024
|
Louise Rodino Klapac Head of R&D, CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
512
-0.74%
|
$61,440
$120.49 P/Share
|
|
Mar 07
2024
|
Bilal Arif Chief Tech Ops Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
506
-1.93%
|
$60,720
$120.49 P/Share
|
|
Mar 05
2024
|
Stephen Mayo |
SELL
Open market or private sale
|
Direct |
3,135
-32.13%
|
$382,470
$122.96 P/Share
|
|
Mar 04
2024
|
Louise Rodino Klapac Head of R&D, CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,728
-2.43%
|
$216,000
$125.32 P/Share
|
|
Mar 04
2024
|
Bilal Arif Chief Tech Ops Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
522
-0.98%
|
$65,250
$125.32 P/Share
|
|
Mar 04
2024
|
Ryan Edward Brown EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,734
-5.45%
|
$216,750
$125.32 P/Share
|
|
Mar 04
2024
|
Ian Michael Estepan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,389
-3.55%
|
$173,625
$125.32 P/Share
|
|
Mar 01
2024
|
Louise Rodino Klapac Head of R&D, CSO |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+7.77%
|
-
|
|
Mar 01
2024
|
Louise Rodino Klapac Head of R&D, CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
778
-1.18%
|
$98,028
$126.19 P/Share
|
|
Mar 01
2024
|
Ryan Edward Brown EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
2,000
-5.91%
|
$250,000
$125.34 P/Share
|
|
Mar 01
2024
|
Ryan Edward Brown EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+15.07%
|
-
|
|
Mar 01
2024
|
Ryan Edward Brown EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
269
-0.96%
|
$33,894
$126.19 P/Share
|
|
Mar 01
2024
|
Richard Barry |
BUY
Grant, award, or other acquisition
|
Direct |
1,846
+0.06%
|
-
|
|
Mar 01
2024
|
Ian Michael Estepan Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,200
-2.98%
|
$153,600
$128.3 P/Share
|
|
Mar 01
2024
|
Ian Michael Estepan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+12.96%
|
-
|
|
Mar 01
2024
|
Ian Michael Estepan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
365
-1.05%
|
$45,990
$126.19 P/Share
|
|
Mar 01
2024
|
Kathryn Jean Boor |
BUY
Grant, award, or other acquisition
|
Direct |
1,846
+18.24%
|
-
|
|
Mar 01
2024
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
1,846
+1.03%
|
-
|
|
Mar 01
2024
|
Michael Andrew Chambers |
BUY
Grant, award, or other acquisition
|
Direct |
1,846
+18.24%
|
-
|
|
Mar 01
2024
|
Bilal Arif Chief Tech Ops Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
365
-0.76%
|
$45,990
$126.19 P/Share
|
|
Mar 01
2024
|
Bilal Arif Chief Tech Ops Officer |
SELL
Open market or private sale
|
Direct |
2,000
-3.51%
|
$258,000
$129.15 P/Share
|
|
Mar 01
2024
|
Bilal Arif Chief Tech Ops Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+17.22%
|
-
|
|
Mar 01
2024
|
Hans Lennart Rudolf Wigzell |
BUY
Grant, award, or other acquisition
|
Direct |
1,846
+7.48%
|
-
|
|
Mar 01
2024
|
Stephen Mayo |
BUY
Grant, award, or other acquisition
|
Direct |
1,846
+15.91%
|
-
|
|
Mar 01
2024
|
Claude Nicaise |
BUY
Grant, award, or other acquisition
|
Direct |
1,846
+9.22%
|
-
|